[1]MOODY J, HICKOK J, SEPTIMUS E. Infection prevention practices in adult ICUs in a large community hospital system experiencing sustained reduction in healthcare-associated (HA) MRSA infections[J]. Am J Infect Control, 2011, 39(5):E94.
[2]STEFANI S, CHUNG D R, LINDSAY J A, et al. Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods[J]. Int J Antimicrob Agents, 2012, 39(4):273-282.
[3]金春梅,朴美花,许顺姬,等. 耐甲氧西林金黄色葡萄球菌的耐药性分析[J].中华医院感染学杂志,2013,23(13):3238-3242.
[4]ZHANG L, RAVIPATI A S, KOYYALAMUDI S R, et al. Anti-fungal and anti-bacterial activities of ethanol extracts of selected traditional Chinese medicinal herbs[J]. Asian Pac J Trop Med, 2013, 6(9):673-681.
[5]CUSHNIE T P, LAMB A J. Recent advances in understanding the antibacterial properties of flavonoids[J]. Int J Antimicrob Agents, 2011,38(2):99-107.
[6]CHEN C H, HUANG T S, WONG C H, et al. Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells[J]. Food Chem Toxicol, 2009, 47(3) :638-644.
[7]OGURA T. A high contrast method of unstained biological samples under a thin carbon film by scanning electron microscopy[J]. Biochem Biophys Res Commun, 2008, 377(1): 79-84.
[8]SULLIVAN D M, GLISSON B S, HODGES P K, et al. Proliferation dependence of topoisomerase Ⅱ-mediated drug action[J]. Biochemistry, 1986, 25(8):2248-2256.
[9]WEBB M R, EBELER S E. A gel electrophoresis assay for the simultaneous determination of topoisomerase I inhibition and DNA intercalation[J]. Anal Biochem, 2003, 321(1):22-30.
[10]廖见培.DNA与小分子药物相互作用的研究[D].长沙:湖南大学,2001.
[11]SCHWALM III N D, VERGHESE B, KNABEL S J. A novel multiplex PCR method for detecting the major clonal complexes of MRSA in nasal isolates from a Pennsylvania hospital[J]. J Microbiol Methods, 2011, 86(3):379-382.
[12]云宝仪, 周磊, 谢明杰,等.黄芩素抑菌活性及其机制的初步研究[J].药学学报,2012,47(12):1587-1592.
[13]CORNEO G, POGLIANI E, BIASSONI D, et al. Inhibition of DNA restriction enzyme digestion by anthracyclines[J].Ric Clin Lab , 1988, 18(1):19-22.
[14]CUSHNIE T P, LAMB A J. Antimicrobial activity of flavonoids[J]. Int J Antimicrob Agents, 2005, 26(5):343-356.
[15]余琼.抗耐甲氧西林金黄色葡萄球菌(MRSA)天然产物的筛选及研究[D].重庆:西南大学,2012.
[16]闻平,俞晓丽,陈蕾,等,黄芩素对耐甲氧西林金黄色葡萄球菌的体外抗菌活性研究[C]//现代化中药制剂发展与中药药理学研究交流会论文集. 北京,中华中医药学会,2009:102-104.
[17]GENTRY A C, OSHEROFF N. Encyclopedia of Biological Chemistry[M]. Nashville: Vanderbilt University School of Medicine Press. 2013:157-168.
[18]NADAL M. Reverse gyrase: An insight into the role of DNA-topoisomerases[J]. Biochimie, 2007, 89(4):447-455.
[19]PATRA N, DE U, KANG J A, et al. A novel epoxypropoxy flavonoid derivative and topoisomerase Ⅱ inhibitor, MHY336, induces apoptosis in prostate cancer cells[J]. Eur J Pharmacol, 2011, 658(2-3):98-107.
[20]SHIOMI K, KURIYAMA I, YOSHIDA H, et al. Inhibitory effects of myricetin on mammalian DNA polymerase, topoisomerase and human cancer cell proliferation[J]. Food Chem, 2013,139(1-4):910-918.
[21]SCHMIDT F, KNOBBE C B, FRANK B, et al. The topoisomerase Ⅱ inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines[J]. Oncol Rep, 2008,19(4):1061-1066.
[22]CANTERO G, CAMPANELLA C, MATEOS S, et al. Topoisomerase Ⅱ inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin[J]. Mutagenesis, 2006, 21(5):321-325.
[23]GRYNBERG N F, CARVALHO M G, VELANDIA J R, et al. DNA topoisomerase inhibitors: biflavonoids from Ouratea species[J]. Braz J Med Biol Res, 2002, 35(7):819-822.
[24]FORTERRE P, GRIBALDO S, GADELLE D, et al. Origin and evolution of DNA topoisomerases[J]. Biochimie, 2007, 89(4):427-446. |